China wants to patent Gilead’s experimental coronavirus drug
Bloomberg Chinese researchers have applied for a local patent on an experimental Gilead Sciences Inc drug that they believe might fight the novel coronavirus outbreak. The Wuhan Institute of Virology — based in the central Chinese city at the epicenter of the epidemic — has applied for a patent in China for the use of the antiviral drug, known as ...
Read More »